Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Osteoporosis, Age-Related Clinical Trial

Official title:
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice

Status Completed

Clinical Trial Summary

The objective of this study was to describe persistence with Prolia® 60 mg administered subcutaneously (SC) every 6 months (Q6M) at 12 and 24 months.

Clinical Trial Description

The study was a multi-center, single-arm, prospective, non-interventional observational study in postmenopausal women with osteoporosis who had been treated with Prolia® for osteoporosis in routine clinical practice. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02732210
Study type	Observational
Source	Amgen
Contact
Status	Completed
Phase
Start date	July 6, 2011
Completion date	April 14, 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03710889` - Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption	Phase 3
Completed	`NCT03512262` - Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)	Phase 3
Completed	`NCT04167150` - Tart Cherry Supplementation and Women's Bone Health Study	N/A
Withdrawn	`NCT02091492` - Teriparatide for Fracture Repair in Humans	Phase 3
Completed	`NCT05197244` - A Culinary Intervention for Bone Health	N/A
Completed	`NCT02467400` - Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism	Early Phase 1
Recruiting	`NCT05927623` - Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men	N/A